logo
  • Home
  • About
    • Leadership
    • Scientific Advisors
    • Board
  • Science
    • Targeting the DDR
    • Clinical Trials
    • Pipeline
  • Investors & Partners
    • Our Investors
    • Our Partners
    • Merck KGaA
    • Novartis
  • Careers
    • Our Opportunities
    • Our Testimonials
    • Our Benefits
    • Core Values
  • News & Events
    • Press release
    • Media coverage
    • Conferences
  • Contact Us

Artios in strong position to accelerate cancer programmes after Arix investment

19 December 2018 | Media coverage

Proactive Investors’ Andrew Scott sits down with Arix Bioscience Plc’s (LON:ARIX) investment director Jonathan Tobin and Niall Martin, chief executive of Artios Pharma to discuss the Series B financing.

https://www.proactiveinvestors.co.uk/companies/stocktube/10188/artios-in-strong-position-to-accelerate-cancer-programmes-after-arix-investment-10188.html

logo

Quick Links

  • Homepage
  • About
  • Science
  • Our Investors
  • Our Partners
  • News & Events
  • Careers
  • Contact Us

Contact

UK Office: +44 (0)1223 867 900
General enquiries: info@artios.com
Careers: HR@artios.com
Finance: Accounts@artios.com

Our career opportunities

Our careers
© Artios Pharma 2022 | Website by Granite 5
Follow on twitter Follow on LinkedIn

Terms & conditions | Privacy policy | Site map

We use cookies to collect data, please see our privacy policy.